Description of Invention: The inventors have developed a transgenic mouse which expresses the human erythropoietin receptor. Erythropoietin is a cytokine or hormone required for the production of red blood cells and acts by binding on early, undifferentiated blood progenitor cells to stimulate red blood cell formation. The model is particularly useful as human infectious agents or gene therapy vectors that selectively target human cells expressing the erythropoietin receptor can be studied.
Background scientific detail may be found in Liu, C., Liu, Z.Y., Shen, K. and Noguchi, C. T. (1997), "Regulated human erythropoietin receptor expression in mouse brain", J. Biol. Chem. 272:32395-32400.
Inventors: No Inventor Information Available.
Portfolios: Gene Based Therapies Gene Based Therapies - Therapeutics Gene Based Therapies - Research Materials Animal Model
For Additional Information Please Contact: No Licensing Specialist Information Available.